These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 12813810)

  • 1. The impact of highly active antiretroviral combination therapy in HIV infected patients in Glasgow.
    Fox R; Gourlay YJ
    Health Bull (Edinb); 2000 Jul; 58(4):309-15. PubMed ID: 12813810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
    Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
    Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients.
    Nuesch R; Geigy N; Schaedler E; Battegay M
    Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):684-7. PubMed ID: 12373504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
    Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Horberg MA; Hurley LB; Klein DB; Follansbee SE; Quesenberry C; Flamm JA; Green GM; Luu T
    Arch Surg; 2006 Dec; 141(12):1238-45. PubMed ID: 17178967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
    Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
    HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
    Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
    Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital-based directly observed therapy for HIV-infected children and adolescents to assess adherence to antiretroviral medications.
    Glikman D; Walsh L; Valkenburg J; Mangat PD; Marcinak JF
    Pediatrics; 2007 May; 119(5):e1142-8. PubMed ID: 17452493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapy.
    Lima VD; Hogg RS; Harrigan PR; Moore D; Yip B; Wood E; Montaner JS
    AIDS; 2007 Mar; 21(6):685-92. PubMed ID: 17413689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in liver-related hospital admissions and deaths in HIV-infected patients since the year 2002.
    Martín-Carbonero L; Sánchez-Somolinos M; García-Samaniego J; Núñez MJ; Valencia ME; González-Lahoz J; Soriano V
    J Viral Hepat; 2006 Dec; 13(12):851-7. PubMed ID: 17109686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Khouli H; Afrasiabi A; Shibli M; Hajal R; Barrett CR; Homel P
    J Intensive Care Med; 2005; 20(6):327-33. PubMed ID: 16280405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first 5 years of the family clinic for HIV at Tygerberg Hospital: family demographics, survival of children and early impact of antiretroviral therapy.
    van Kooten Niekerk NK; Knies MM; Howard J; Rabie H; Zeier M; van Rensburg A; Frans N; Schaaf HS; Fatti G; Little F; Cotton MF
    J Trop Pediatr; 2006 Feb; 52(1):3-11. PubMed ID: 15947012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy.
    Baekken M; Os I; Sandvik L; Oektedalen O
    J Hypertens; 2008 Nov; 26(11):2126-33. PubMed ID: 18854751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do hospitalists or physicians with greater inpatient HIV experience improve HIV care in the era of highly active antiretroviral therapy? Results from a multicenter trial of academic hospitalists.
    Schneider JA; Zhang Q; Auerbach A; Gonzales D; Kaboli P; Schnipper J; Wetterneck TB; Pitrak DL; Meltzer DO
    Clin Infect Dis; 2008 Apr; 46(7):1085-92. PubMed ID: 18444829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area.
    Martínez E; Milinkovic A; Buira E; de Lazzari E; León A; Larrousse M; Loncá M; Laguno M; Blanco JL; Mallolas J; García F; Miró JM; Gatell JM
    HIV Med; 2007 May; 8(4):251-8. PubMed ID: 17461853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study.
    Patel K; Hernán MA; Williams PL; Seeger JD; McIntosh K; Van Dyke RB; Seage GR;
    Clin Infect Dis; 2008 Feb; 46(4):507-15. PubMed ID: 18199042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.